DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the Invicta Diagnostic Limited (INVICTA) share price today?

Invicta Diagnostic Limited (INVICTA) is trading at ₹69 on the NSE, up 0.00% on the day. Source: DocStoX.

What is the PE ratio of Invicta Diagnostic Limited?

Invicta Diagnostic Limited has a price-to-earnings (PE) ratio of 17.6 in the Healthcare sector.

What is the market capitalisation of Invicta Diagnostic Limited?

Invicta Diagnostic Limited has a market capitalisation of approximately ₹87 crore.

Is Invicta Diagnostic Limited a profitable company?

Invicta Diagnostic Limited generates a return on equity of 9.8% with a net profit margin of 15.1%. That is a modest return on shareholder capital.

What is the 52-week high and low of INVICTA?

Invicta Diagnostic Limited (INVICTA) has traded between ₹58.1 and ₹105 over the past 52 weeks, against a current price of ₹69.

Invicta Diagnostic Limited

₹69.00▲ +0.00 (+0.00%)

INVICTA·NSE·Healthcare

Market Cap

86.75 Cr

PE Ratio

17.65

Volume

4,800

Day High - Low

69.00 - 69.00

52W High-Low

105.00 - 58.10

₹69.00▲ +0.00 (+0.00%)

Market Cap86.75 Cr

PE Ratio17.65

Volume4,800

Day High - Low69.00 - 69.00

52W High-Low105.00 - 58.10

Invicta Diagnostic Limited (INVICTA): company summary

Annual revenue rose 7.5% to ₹32 crore, but annual net profit fell 1.2% to ₹5 crore.

Invicta Diagnostic Limited (INVICTA) is a micro-cap Healthcare company valued at ₹87 crore operating in Healthcare Service Provider on the NSE and BSE.

Recent price move: Invicta Diagnostic Limited last traded at ₹69, unchanged on the day.
Financial performance: Annual revenue rose 7.5% to ₹32 crore, but annual net profit fell 1.2% to ₹5 crore. The latest quarter saw revenue drop 48.8% to ₹15 crore and net profit fall 84.0% to ₹1 crore compared to the same quarter a year earlier.
Valuation multiples: The stock trades at 17.6 times earnings, a discount to the Healthcare median of 32.0, 1.74 times book value.
Things to watch: The company's net profit margin narrowed 1.3 percentage points to 15.1%. The latest quarter's net profit fell 84.0% compared to the same quarter a year earlier. The stock is 36.6% below its 52-week high.
Where it stands: Invicta Diagnostic Ltd ended the latest quarter with revenue of ₹15 crore and net profit of ₹1 crore, marking a sharp decline compared to the same quarter a year earlier. The stock is 36.6% below its 52-week high.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

5.9/10

Fair

Fair Value

ROE

9.83%

Average

P/E

17.65x

Fair

Debt / Equity

0.07

Low

Industry

Healthcare

Healthcare Service Provider

Overall View

Mixed

Price performance

52W₹58.10

₹105.00

DocStoX take

Supported by risk (8.4) and growth (8.2), but held back by momentum (1.2). Risk looks strong at 8.4, but that is offset by momentum at 1.2. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence

5.9

/10

Fair

Quality

Solid

ROE 9.8%

Valuation

Rich

P/E 17.6×

Growth

Strong

Revenue +63.1% 3Y CAGR

Risk

Low risk

D/E 0.07

Momentum

Weak

23% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹69

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹87 Cr

52W High / Low

₹105 / ₹58

Dividend Yield

0.00%

Promoter Holding

66.70%

EPS (TTM)

₹3.91

Book Value

₹39.71

Key highlights

Revenue compounding 63% a year
Profit compounding 40% a year
Low leverage — D/E 0.07
Momentum is weak (1.2/10)
Near the bottom of its 52-week range (23%)

4 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Healthcare Service Provider

Explore Invicta Diagnostic Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Invicta Diagnostic Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Invicta Diagnostic Limited with peers

Invicta Diagnostic Limited vs Sun Pharmaceutical Industries Limited Invicta Diagnostic Limited vs Divi's Laboratories Limited Invicta Diagnostic Limited vs Torrent Pharmaceuticals Limited Invicta Diagnostic Limited vs Apollo Hospitals Enterprise Limited Invicta Diagnostic Limited vs Zydus Lifesciences Limited Invicta Diagnostic Limited vs Laurus Labs Limited

Related tools & concepts

Value Invicta Diagnostic Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

INVICTA newsLatest coverage & filings Open screenerFilter the whole market